MR

Markus Von Raumer

IP Idorsia Pharmaceuticals: 12 patents #4 of 104Top 4%
AP Actelion Pharmaceuticals: 2 patents #74 of 188Top 40%
GG Gruenenthal Gmbh: 2 patents #120 of 331Top 40%
RI Recordati Ireland: 1 patents #8 of 18Top 45%
SA Solvias Ag: 1 patents #25 of 65Top 40%
📍 Allschwil, CH: #29 of 309 inventorsTop 10%
Overall (All Time): #228,247 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
12297189 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Martin Bolli 2025-05-13
12227532 Crystalline forms Daniel Leuenberger, Stefan Reber 2025-02-18
11680058 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Martin Bolli 2023-06-20
11555025 Crystalline form of N-[1-(5-cyano-pyridin-2-ylmethyl)-1 H-pyrazol-3-yl]-2- [4-(1-trifluoromethyl-cyclopropyl)-phenyl-acetamide Bibia Heidmann 2023-01-17
11365209 Crystalline forms Daniel Leuenberger, Stefan Reber 2022-06-21
11339148 Crystalline forms of the CXCR7 receptor antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide Philippe Guerry 2022-05-24
11059803 Crystalline form of N-[1-(5-cyano-pyridin-2- ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-acetamide Bibia Heidmann 2021-07-13
10919881 Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan Martin Bolli, Philipp KOHLER, Ivan SCHINDELHOLZ 2021-02-16
10730896 Crystalline forms Daniel Leuenberger, Stefan Reber 2020-08-04
10351560 Crystalline forms Hamed Aissaoui, Christoph Boss, Patrick Bouis, Julien Hazemann, Romain Siegrist 2019-07-16
10023560 Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist Christoph Boss, Christine Brotschi, Markus Gude, Bibia Heidmann, Thierry Sifferlen +1 more 2018-07-17
9914720 Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists Christoph Boss, Christine Brotschi, Markus Gude, Bibia Heidmann, Thierry Sifferlen +1 more 2018-03-13
9790208 Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist Christoph Boss, Christine Brotschi, Markus Gude, Bibia Heidmann, Thierry Sifferlen +1 more 2017-10-17
9062014 Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-0-tolyl-thiazolidin-4-one Nicholas Bonham, Stephan Buchmann, Alex Eberlin, Christoph Imboden 2015-06-23
8492555 Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester Stefan Abele, Stéphanie Combes, Jacques-Alexis Funel, Kurt Hilpert, Francis Hubler +2 more 2013-07-23
8058476 HCI polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol Michael Gruss, Andreas Fischer, Markus Kegel, Wolfgang Hell, Joerg Berghausen +1 more 2011-11-15
7892354 Process for the parallel detection of crystalline forms of molecular solids Fritz Blatter, Martin Szelagiewicz 2011-02-22
7884247 Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof Michael Gruss, Wolfgang Hell, Martin Szelagiewicz, Joerg Berghausen, Susan Margaret De Paul 2011-02-08
7683179 Lercanidipine salts Amedeo Leonardi, Gianni Motta 2010-03-23